Saga Legal has advised Ultrahuman, a Bengaluru-based health technology company building one of the world's most comprehensive wearable and ambient health ecosystems, on its ₹100 crore venture debt infusion from Alteria Capital.
This growth financing will enable Ultrahuman to strengthen its innovation roadmap, scale its market expansion efforts, deepen sports and research partnerships, and accelerate development of new feature-led and software-driven revenue streams. The transaction supports Ultrahuman's strategy of capital-efficient and profitable growth, reinforcing its mission to make advanced, actionable health insights accessible globally.
Ultrahuman's product suite includes the Ultrahuman Ring AIR, M1 CGM, Blood Vision, Ultrahuman Home, and Cycle & Ovulation Pro, positioning the company at the forefront of next-generation health optimisation technologies.
The transaction team at Saga Legal comprised Neeraj Vyas (Partner), Mehak Chadha (Associate) and Cyril Chacko (Associate).
This financing marks a significant step in Ultrahuman's rapidly expanding global footprint and underscores investor confidence in India's growing health-tech and wearable innovation ecosystem.